renal registry of turkey: change of renal replacement ... ·
TRANSCRIPT
54
ER
A
ePosters supported by
F. Hoffmann- La Roche Ltd.
Renal Registry of Turkey: Change of Renal Replacement Modalities in the Last 15 yearsSeyahi N1 , Ates K1,Sezer S1, Altiparmak MR1, Tonbul Z1, Duman S1, Kocyigit I1, Suleymanlar G1
1Turkish Society of Nephrology Registry Committee
BACKGROUND
❖ The national renal registry studies provide epidemiologic and demographic
picture of patients with renal diseases and treatment and local follow-up
practices..
❖ Turkey ranks seventeenth among the world’s most populous countries with
a population of approximately 80 million in 2016 and annual rate of growth
of population as 1.35%.
❖ Founded in 1970, TSN has been coordinating annual national renal
registry with its own resources since 1990. The registry has been
collecting data on nephrology, dialysis and transplantation from all centers
treating patients with renal diseases in Turkey.
❖ The results of the registry have been published by TSN as yearly booklets
and are available online (http://www.tsn.org.tr/) in English since 1998,
which are comprehensive source on national nephrology, dialysis and
transplantation status in Turkey. The results of the registry have also been
included in ERA-EDTA and USRDS reports.
❖ In this poster, detailed and updated status of RRT for ESRD in Turkey
depending on the national registry data for the last 10 years is presented.
SUBJECTS AND METHODS
Data collection
❖ The registry form includes questions on facilities of the centre;
characteristics of patients with renal diseases, dialysis patients, or patients
who had kidney transplantation; and treatment and follow-up procedures
for these patients.
❖ Since 2006, centers have been entering their data to a central electronic
database that is managed by TSN. Since 2013 TSN registry is in close
collaboration with Ministry of Health and also recruiting data from their
database
RESULTS
Incidence and prevalence of ESRD leading to RRT
❖ The number of patients on renal replacement therapy is increasing, at
the end of 2015, 73660 patients were on renal replacement therapy. The
prevalence and incidence of end-stage renal disease was 935 and 147
per million population respectively.Both prevalence and incidence of
ESRD show tendency of increase over the last years, particularly
between 2001 and 2015 (Figure 1).
❖ The most common RRT modality in prevalent ESRD was hemodialysis
(77.3% of patients) followed by peritoneal dialysis (5.3%) and
transplantation (17.4%) in 2015 (Table 1). While the numbers of
hemodialysis and transplant patients increased consistently from 2008 to
2015, number of peritoneal dialysis patients decreased during this
period.
Figure 1. The point prevalence and incidence of ESRD leading to
RRT per pmp in Turkey.
Demographics/ Etiology of hemodialysis patients
❖ The total number of patients who started hemodialysis in 2015 is
9590. All of the patients who underwent hemodialysis treatment,
56.4% were male, 43.6% were female and their age distributions are
shown in Table 2.
❖ Diabetes mellitus (41%) was the leading etiological factor in these
patients, followed by hypertension (25.2%), glomerulonephritis
(5.5%), polycystic kidney disease (3.8%), amyloidosis (1.9%) and
other reasons. 11% of patients have no primary disease.
❖ The three most common etiologies for ESRD leading to RRT were
diabetes mellitus, hypertension, and chronic glomerulonephritis. The
frequency of diabetes mellitus has increased rapidly in recent years
(Figure 2).
❖ It is remarkable that the rate of diabetes mellitus and hypertension
increased in patients with ESRD while renal pathologies like chronic
glomerulonephritis, urologic disease etc. decreased over the 15
years of registry (Figure 3).
Figure 2. Trends in the most common underlying etiologic causes of RRT
patients in Turkey.
Clinical characteristics of hemodialysis patients
❖ The change in the technical characteristics of hemodialysis treatment is
shown in Table 3. Synthetic and semi-synthetic membranes as well as
high-flux membranes appear to be used increasingly. Recently, the
frequency of hemodialysis is three times a week in the majority of patients
❖ There was an increasing tendency in Kt / V over the years
❖ In the majority of patients (69.9%) Kt / V was above 1.4 at the end of 2015.
Kidney Transplantation
❖ While living donor is the most common donor source in kidney
transplantation patients, a large proportion of patients final situation
is functioning graft as of the end of 2015 (Table 4 and 5).
Figure 6. Percentage of cadaveric donor over the years.
CONCLUSION
❖ In conclusion,RRT modality in Turkey is focused primarily on
hemodialysis. The trend of the past 15 years in Turkish Renal
Registry indicates that while the the number of peritoneal
dialysis decreases, an increase in the number of
transplantation is observed.
❖ However, It is necessary to achieve a significant increase in
the cadaveric donor rather than living donor transplantation.
n %
Hemodialysis 56951 77.31
Peritoneal dialysis 3909 5.31
Transplantation * 12800 17.38
Total 73660 100.00
TABLE 2. Distribution of chronic HD/PD patients or patients followed with functioning graft (including pediatric patients) according to RRT type as of the end of 2015.TABLE 2. Distribution of chronic HD/PD patients or patients followed with functioning graft (including pediatric patients) according to RRT type as of the end of 2015.TABLE 2. Distribution of chronic HD/PD patients or patients followed with functioning graft (including pediatric patients) according to RRT type as of the end of 2015.
Table 1. Distribution or according to RRT type as of the end of 2015.
AgeMale Female Total
n % n % n %
0-19 62 0.65 58 0.60 120 1.25
20-44 701 7.31 435 4.54 1136 11.85
45-64 2265 23.62 1478 15.41 3743 39.03
65-74 1444 15.06 1166 12.16 2610 27.22
≥75 1018 10.61 963 10.04 1981 20.65
Total 5490 57.25 4100 42.75 9590 100.00
Table 2. Age and gender distribution of incident hemodialysis patients
in 2015.
2003 2004 2005 2006 2007 2008 2009 2013 2014 2015
Type of vascular access
AV fistula 87,5 90,1 88,7 85,7 86,0 85,4 84,0 82,9 81,1 80,4
Permanent (tunnelled)
catheter
3,5 3,5 3,6 6,9 7,0 7,7 9,3 11,7 13,4 14,4
AV graft 3,5 2,6 2,7 3,2 2,9 2,9 2,7 1,8 1,6 1,5
Others 5,5 3,8 5,0 4,2 4,1 4,0 4,0 3,6 3,9 3,8
Dialyser type
Synthetic - 54,0 43,0 62,8 67,2 60,3 65,0 58,9 - -
Semi-synthetic - 35,8 47,8 22,1 19,1 17,6 14,0 7,0 - -
High-flux - 8,9 9,0 15,0 13,7 21,8 21,0 34,1 33,3 36,3
Kuprofan - 1,3 0,2 0,1 0,0 0,3 0,0 0 - -
HD frequency
Once weekly 1,9 1,6 1,7 1,5 0,9 0,9 0,9 0,6 0,6 0,5
Twice weekly 15,6 13,6 10,2 9,3 7,8 7,5 7,0 7,7 7,9 8,0
3 times weekly 82,5 84,8 88,1 89,2 89,9 90,2 90,1 90,1 90,8 90,7
Nocturnal HD or >3 times
weekly- - - - 1,4
1,4 2,0 0,7 0,8 0,8
Kt/V urea value
<1,20 - 36,3 27,8 14,5 12,7 11,3 10,2 11,0 11,3 9,8
≥1,20 - 63,7 72,2 85,5 87,3 88,8 89,8 89,0 88,7 90,2
Table 3. Changes in the technical characteristics of hemodialysis treatment over
the years (expressed as percentage of patients)
0
5
10
15
20
25
30
35
40
45
1995 2001 2007 2009 2010
2011 2012 2013 2014 2015
DM CGN HT PKD PN OTHER UNKNOWN
Figure 3. Changes in primary etiology over the years in patients
receiving HD
Peritoneal Dialysis
❖ The number of peritoneal dialysis patients decreased from 2008 to 2015
(Figure 4) .
Figure 4. Trends in the number of peritoneal dialysis patients over the
years
n %
Followed with functioning graft 2463 97.20
Returned to dialysis 28 1.10
Died 43 1.70
Total 2534100.0
0
n %
Kidney transplantation from living donor 2534 79.09
Kidney transplantation from deceased donor 670 20.91
Total 3204 100.00
Table 4. Distribution of kidney transplantation patients according to
donor source in 2015.
Table 5. Distribution of all kidney transplantation patients transplanted
in 2015 according to final situation as of the end of 2015.
❖ The number of translplantations over the years is shown in
Figure 5. While an increase in the all of transplantation was
observed over the years, a lower rate increase in the number of
cadaveric transplants is observed( Figure 6).
Figure 5. Number of transplantation over the years
1--REGSeyahi Nurhan DOI: 10.3252/pso.eu.54ERA.2017
Registry posters